Related Experiment Video
Updated: Dec 30, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
PAS kinase deficiency reduces aging effects in mice.
Pilar Dongil1,2, Ana Pérez-García1,2, Verónica Hurtado-Carneiro1,3
1Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University of Madrid, Institute of Medical Research at the Hospital Clínico San Carlos (IdISSC), Ciudad Universitaria, Madrid, Spain.
Aging impairs mitochondrial function and increases oxidative stress. However, PASK deficiency in aged mice protected against these effects, improving metabolic health and suggesting PASK as a potential therapeutic target for aging.
Area of Science:
- Gerontology
- Molecular Biology
- Metabolic Research
Background:
- Aging is associated with impaired mitochondrial function, increased oxidative stress, and metabolic dysregulation.
- Nutrient-sensing pathways, including PAS Domain Kinase (PASK), regulate cellular homeostasis and are implicated in aging.
- PASK is a known regulator of hepatic metabolic balance and mitochondrial homeostasis.
Purpose of the Study:
- To investigate the role of PASK in hepatic oxidative stress and metabolic function during aging.
- To analyze the impact of PASK deficiency on mitochondrial function, glucose tolerance, and insulin resistance in aged mice.
Main Methods:
- Analysis of mitochondrial function, oxidative stress markers (ROS/RNS), and key metabolic regulators (PGC1a, SIRT1, NRF2, GCLm, HO1, CS activity) in aged PASK-deficient and wild-type mice.
- Assessment of glucose tolerance, insulin sensitivity (HOMA-IR), and lipid parameters.
- Evaluation of longevity gene (FoxO3a) and cell repair marker (PCNA) expression.
Main Results:
- Hepatic PASK mRNA levels decreased with age.
- Aged PASK-deficient mice exhibited reduced oxidative stress (ROS/RNS) compared to aged WT mice.
- PASK deficiency preserved NRF2, GCLm, HO1, and CS activity, alongside FoxO3a and PCNA expression, suggesting enhanced antioxidant defense and cellular repair.
- PASK-deficient mice demonstrated improved insulin sensitivity and normal glucose tolerance.
Conclusions:
- PASK deficiency confers protection against age-related hepatic oxidative stress and metabolic decline.
- PASK plays a significant role in regulating metabolic homeostasis and mitigating oxidative damage during aging.
- Targeting PASK may represent a novel therapeutic strategy for reducing age-associated damage and improving metabolic health.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Effect of Aging on Tissues
Pharmacodynamics in Geriatric Patients: Effects of Age

